Intra-Cellular Therapies, Inc. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intra-Cellular Therapies, Inc. for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 18.03 | 25,500 | 459,765 | 191 | 25.7 K to 191 (-99.26 %) |
| Jan 10 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 17.46 | 772 | 13,479 | 12,373 | 13.1 K to 12.4 K (-5.87 %) |
| Jan 10 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 17.48 | 6,604 | 115,438 | 1,088,707 | 1.1 M to 1.1 M (-0.60 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 103,021 | 0 | 103,021 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 15.47 | 138,473 | 2,142,177 | 138,473 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,604 | 0 | 6,604 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,257 | 0 | 22,516 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 17.08 | 11,257 | 192,270 | 1,095,311 | 1.1 M to 1.1 M (-1.02 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,604 | 0 | 1,106,568 | 1.1 M to 1.1 M (+0.60 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,257 | 0 | 1,099,964 | 1.1 M to 1.1 M (+1.03 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 1,554 | 0 | 1,554 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 2,648 | 0 | 5,298 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 17.37 | 1,185 | 20,583 | 13,145 | 14.3 K to 13.1 K (-8.27 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 1,554 | 0 | 14,330 | 12.8 K to 14.3 K (+12.16 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 2,648 | 0 | 12,776 | 10.1 K to 12.8 K (+26.15 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 2,648 | 0 | 5,298 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 15.60 | 1,115 | 17,394 | 29,397 | 30.5 K to 29.4 K (-3.65 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 2,648 | 0 | 30,512 | 27.9 K to 30.5 K (+9.50 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.00 | 3,108 | 0 | 3,108 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.00 | 5,297 | 0 | 10,596 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 17.49 | 1,870 | 32,706 | 66,732 | 68.6 K to 66.7 K (-2.73 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 15.67 | 3,192 | 50,019 | 68,602 | 71.8 K to 68.6 K (-4.45 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.00 | 3,108 | 0 | 71,794 | 68.7 K to 71.8 K (+4.52 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.00 | 5,297 | 0 | 68,686 | 63.4 K to 68.7 K (+8.36 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | M | 0.00 | 3,108 | 0 | 3,108 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | M | 0.00 | 5,297 | 0 | 10,596 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 17.49 | 1,560 | 27,284 | 25,691 | 27.3 K to 25.7 K (-5.72 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 15.75 | 2,660 | 41,895 | 27,251 | 29.9 K to 27.3 K (-8.89 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | M | 0.00 | 3,108 | 0 | 29,911 | 26.8 K to 29.9 K (+11.60 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | M | 0.00 | 5,297 | 0 | 26,803 | 21.5 K to 26.8 K (+24.63 %) |
| Jan 03 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | P | 14.48 | 1,001 | 14,494 | 36,608 | 35.6 K to 36.6 K (+2.81 %) |
| Jan 03 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Buy | P | 14.48 | 949 | 13,742 | 9,570 | 8.6 K to 9.6 K (+11.01 %) |